News|Articles|August 1, 2025
How One Neuro Brand Cut Through Prior Auth Barriers
Case study on how a neuro biologic brand leveraged SamaCare’s insights and interventions platform to decrease patient access friction and improve patient starts.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Related Content
Trending on PharmExec
1
Eli Lilly’s Oral Weight Loss Pill Prescribed Over 1,000 Times in First Days on Market
2
Eli Lilly Releases Updated Safety Data for Foundayo Following FDA’s Request
3
Inside Pharma's Revenue Engine: The Gross-to-Net Reckoning
4
The Turning Point for Oral Biologics: Q&A With Morten Graugaard
5